Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Lebanon, New Hampshire 25 trials found
New Search
Filter
Trial Phase
Study Type
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
PHASE2INTERVENTIONAL Orange, California +4 more
RECRUITING
CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth
PHASE2INTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study of Trilaciclib and Lurbinectidin
PHASE2INTERVENTIONAL Lebanon, New Hampshire +1 more
RECRUITING
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
PHASE2INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
PHASE2INTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer
NAINTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
PHASE2INTERVENTIONAL West Haven, Connecticut +4 more
RECRUITING
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Healthy Homes Study
NAINTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
PHASE1INTERVENTIONAL Lebanon, New Hampshire
RECRUITING
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
PHASE2INTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Telmisartan in Prostate Cancer
PHASE1INTERVENTIONAL Lebanon, New Hampshire
RECRUITING
Filter Trials
Trial Phase
Study Type